MME and congestive heart failure: LCZ696, consisted of neprilysin (NEP) inhibitors (sacubitril, PubChem CID:9811834) and angiotensin II receptor type 1 (AT1) antagonists (valsartan), is developed to treat CHF and hypertension7.